Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
Recruiting · NCT06940388 · Registry updated 2025-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Recruiting | Phase 2 | 2025-07-24 | NCT06940388 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| brenner baruch | 1 |
| Johannes Gutenberg University Mainz | 34 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital | Petah Tikva | Israel | 1 |
| Johannes Gutenberg-University Clinic, Mainz, Germany 1.Dept. Medicine, Prof. Peter R. Galle | Mainz | Germany | 1 |